Svenska Cellulosa AB SCA Class A · OMXSTO:SCA_A
Svenska Cellulosa AB SCA Class A — SCA — UBS European Conference in London 2013
16 slides from Svenska Cellulosa AB SCA Class A's conference presentation, Nov 12, 2013
Slide 1: UBS European Conference in London
UBS European Conference in London Jan Johansson, President and CEO
Slide 2: Key events 2012 & 2013
Key events 2012 & 2013 Divestment of the Packaging business, excluding the two kraftliner mills Acquisition of Georgia-Pacific’s European tissue operations Acquired majority ownership in Vinda Strengthened positions in emerging markets Acquisition of Everbeauty in Asia Acquisition of PIS
Slide 3: SCA Group
SCA Group Leading global hygiene and forest products company Net sales in 2012 of SEK 85bn 36,000 employees Sales in about 100 countries #1 or #2 positions in close to 80 countries Strong brands; TENA and Tork are leading global brands for incontinence products and AFH tissue Europe’s
Slide 4: Acquired majority ownership in Vinda
Acquired majority ownership in Vinda Leading Tissue company in China 2012 Sales: approximately SEK 5bn Sales CAGR* last 3 years approximately 30% Extensive distribution network across China Strong brand No. 3 in China with 12% market share * Compound Annual Growth Rate November 2013 UBS Eu
Slide 5: Leading Market positions
Leading Market positions Globally and regionally Nordic region Europe Incontinence products: 1 Tissue: 1 North America Baby diapers: 1 Incontinence products 1 Incontinence products: 2 AFH tissue: 1 Baby diapers: 2 AFH tissue: 3 Consumer tissue: 2 Feminine care: 3 Mexico Feminine care: 2 Private fore
Slide 6: SCA Group: 2012 sales and EBIT by Business Area
SCA Group 2012 sales and EBIT by Business Area Sales by Business Area EBIT by Business Area Forest Products Personal Care Forest Products Personal Care 21% 15% 30% 35% 49% 50% Tissue Tissue November 2013 UBS European Conference in London 6
Slide 7: SCA Group: 2012 sales by Product Category
SCA Group 2012 sales by Product Category Personal Care Tissue Feminine care 14% Incontinence products 38% 56% 30% 62% AFH tissue Baby diapers 73% branded Consumer tissue Approx. 50% branded November 2013 UBS European Conference in London 7
Slide 8: SCA Group's Priorities
SCA Group’s Priorities EFFICIENCY INNOVATION GROWTH November 2013 UBS European Conference in London 8
Slide 9: Financial Targets
Financial Targets Group ROCE** 13% Debt/Equity 0.70 Debt payment capacity above 35% Dividend policy 1/3 of cash flow from current operations Business areas Sales growth* ROCE** Personal Care 5-7% 30% Tissue 3-4% 15% Forest Products in line with market in top quartile * Annual organic sales growth **
Slide 10: Efficiency programs
Efficiency programs Hygiene business cost and productivity program Achieved cost savings Q3 2013: SEK 270m Annualized cost savings in Q3 2013: approx. EUR 130m Total annual cost savings of EUR 300m, full effect in 2015 Georgia-Pacific synergies Achieved cost savings Q3 2013: SEK 120m A
Slide 11: Innovation drives Profitable growth
Innovation drives Profitable growth Strengthens market positions and profitability November 2013 UBS European Conference in London 11
Slide 12: Growth
Growth Net sales increased 14%* Good sales growth in emerging markets Personal Care increased with 13%** Tissue increased with 15%** Acquired majority ownership in Vinda Investment in India * 9M 2013 compared to 9M 2012, excluding exchange rate effects and divestments ** 9M 2013 compared
Slide 13: Market drivers
Market drivers Good growth opportunities Global population growth An aging population Increased market penetration Higher disposable income Customers and consumers demand more comfort and sustainability November 2013 UBS European Conference in London 13
Slide 14: Hygiene Products
Hygiene Products High potential in markets with low penetration Usage of Hygiene products Units/capita/year Units/child/year Units/woman/year Kg/capita/year North America Western Europe Eastern Europe Latin America Asia November 2013 UBS European Conference in London 14
Slide 15: 9M 2013 vs. 9M 2012 Summary
9M 2013 vs. 9M 2012 Summary Sales growth 14%* EBIT increased 15%** Higher sales and profits in Personal Care and Tissue Lower sales and profits in Forest Products Efficiency programs delivering according to plan Several product launches * Excluding exchange rate effects and divestments *
Slide 16: Slide 16